Oruka Therapeutics (ORKA) Other Non-Current Assets (2010 - 2026)

Oruka Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $103000.0 for Q1 2026.

• On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $103000.0 in Q1 2026; TTM through Mar 2026 was $103000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $103000.0, up 139.53% from the prior year.
• Other Non-Current Assets steadied at $103000.0 in Q1 2026 per ORKA's latest filing, from $103000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $103000.0 in Q1 2025 and bottomed at $12000.0 in Q3 2023.
• The 5-year median for Other Non-Current Assets is $18000.0 (2022), against an average of $44529.4.
• Across the five-year window, Other Non-Current Assets sank 33.33% in 2023 and soared 758.33% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $18000.0 in 2022, then tumbled by 33.33% to $12000.0 in 2023, then surged by 258.33% to $43000.0 in 2024, then soared by 139.53% to $103000.0 in 2025, then changed by 0.0% to $103000.0 in 2026.
• Per Business Quant, the three latest ORKA Other Non-Current Assets figures stand at $103000.0 (Q1 2026), $103000.0 (Q4 2025), and $103000.0 (Q3 2025).